Recent publications on Cancer

Lambert R, Kudo SE, Vieth M, Allen JI, Fujii H, Fujii T, Kashida H, Matsuda T, Mori M, Saito H, Shimoda T, Tanaka S, Watanabe H, Sung JJ, Feld AD, Inadomi JM, O'Brien MJ, Lieberman DA, Ransohoff DF, Soetikno RM, Zauber A, Teixeira CR, Rey JF, Jaramillo E, Rubio CA, Van Gossum A, Jung M, Jass JR, Triadafilopoulos G. Pragmatic classification of superficial neoplastic colorectal lesions.  Gastrointest Endosc. 2009;70(6):1182-99. Epub 2009 Oct 31. PubMed

Elmore JG, Jackson SL, Abraham L, Miglioretti DL, Carney PA, Geller BM, Yankaskas BC, Kerlikowske K, Onega T, Rosenberg RD, Sickles EA, Buist DS. Variability in interpretive performance at screening mammography and radiologists' characteristics associated with accuracy.  Radiology. 2009;253(3):641-51. Epub 2009 Oct 28. PubMed

Bosco JL, Lash TL, Prout MN, Buist DS, Geiger AM, Haque R, Wei F, Silliman RA. Breast cancer recurrence in older women five to ten years after diagnosis.  Cancer Epidemiol Biomarkers Prev. 2009;18(11):2979-83. Epub 2009 Oct 20. PubMed

Loggers ET, Maciejewski PK, Paulk E, Desanto-Madeya S, Nilsson M, Viswanath K, Wright AA, Balboni TA, Temel J, Stieglitz H, Block S, Prigerson HG. Racial differences in predictors of intensive end-of-life care in advanced cancer patients. J Clin Oncol. 2009;27(33):5559-64. Epub 2009 Oct 5. PubMed

Miglioretti DL, Gard CC, Carney PA, Onega TL, Buist DS, Sickles EA, Kerlikowske K, Rosenberg RD, Yankaskas BC, Geller BM, Elmore JG. When radiologists perform best: the learning curve in screening mammogram interpretation.  Radiology. 2009;253(3):632-40. Epub 2009 Sep 29. PubMed

Wang W, Lau R, Yu D, Zhu W, Korman A, Weber J. PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(Hi) regulatory T cells. Int Immunol. 2009 Sep;21(9):1065-77. Epub 2009 Aug 3. PubMed

Ambrosone CB, Barlow WE, Reynolds W, Livingston RB, Yeh IT, Choi JY, Davis W, Rae JM, Tang L, Hutchins LR, Ravdin PM, Martino S, Osborne CK, Lyss AP, Hayes DF, Albain KS. Myeloperoxidase genotypes and enhanced efficacy of chemotherapy for early-stage breast cancer in swog-8897.  J Clin Oncol. 2009;27(30):4973-9. Epub 2009 Sep 14. PubMed

Gallagher TH, Cook AJ, Brenner RJ, Carney PA, Miglioretti DL, Geller BM, Kerlikowske K, Onega TL, Rosenberg RD, Yankaskas BC, Lehman CD, Elmore JG. Disclosing harmful mammography errors to patients.  Radiology. 2009;253(2):443-52. Epub 2009 Aug 25. PubMed

Li CI, Daling JR, Porter PL, Tang MT, Malone KE. Adjuvant hormonal therapy for breast cancer and risk of hormone receptor-specific subtypes of contralateral breast cancer.  Cancer Res. 2009;69(17):6865-70. Epub 2009 Aug 25. PubMed

Buist DS, Chubak J, Prout M, Yood MU, Bosco JL, Thwin SS, Gold HT, Owusu C, Field TS, Quinn VP, Wei F, Silliman RA. Referral, receipt, and completion of chemotherapy in patients with early-stage breast cancer older than 65 years and at high risk of breast cancer recurrence.  J Clin Oncol. 2009;27(27):4508-14. Epub 2009 Aug 17. PubMed

Choi JY, Barlow WE, Albain KS, Hong CC, Blanco JG, Livingston RB, Davis W, Rae JM, Yeh IT, Hutchins LF, Ravdin PM, Martino S, Lyss AP, Osborne CK, Abeloff MD, Hayes DF, Ambrosone CB. Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial.  Clin Cancer Res. 2009;15(16):5258-66. Epub 2009 Aug 11. PubMed

Aiello Bowles EJ, Tuzzio L, Ritzwoller DP, Williams AE, Ross T, Wagner EH, Neslund-Dudas C, Altschuler A, Quinn V, Hornbrook M, Nekhlyudov L. Accuracy and complexities of using automated clinical data for capturing chemotherapy administrations: implications for future research.  Med Care. 2009;47(10):1091-7. Epub 2009 Jul 30. PubMed

Tubbs R, Barlow WE, Budd GT, Swain E, Porter P, Gown A, Yeh IT, Sledge G, Shapiro C, Ingle J, Haskell C, Albain KS, Livingston R, Hayes DF. Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of her2 and top2a status.  J Clin Oncol. 2009;27(24):3881-6. Epub 2009 Jul 20. PubMed

Mack JW, Block SD, Nilsson M, Wright A, Trice E, Friedlander R, Paulk E, Prigerson HG. Measuring therapeutic alliance between oncologists and patients with advanced cancer: the Human Connection Scale. Cancer. 2009;115(14):3302-11. PubMed

Rebbeck TR, Mitra N, Domchek SM, Wan F, Chuai S, Friebel TM, Panossian S, Spurdle A, Chenevix-Trench G; kConFab, Singer CF, Pfeiler G, Neuhausen SL, Lynch HT, Garber JE, Weitzel JN, Isaacs C, Couch F, Narod SA, Rubinstein WS, Tomlinson GE, Ganz PA, Olopade OI, Tung N, Blum JL, Greenberg R, Nathanson KL, Daly MB. Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers. Cancer Res. 2009 Jul 15;69(14):5801-10. doi: 10.1158/0008-5472.CAN-09-0625. Epub 2009 Jul 7. PubMed

Gallagher TH. A 62-year-old woman with skin cancer who experienced wrong-site surgery. JAMA. 2009;302(6):669-77. Epub 2009 Jul 7. PubMed

Aiello Bowles EJ, Geller BM. Best ways to provide feedback to radiologists on mammography performance. AJR Am J Roentgenol. 2009;193(1):157-64. PubMed

Barlow WE. Overview of methods to estimate the medical costs of cancer.  Med Care. 2009;47(7 Suppl 1):S33-6. PubMed

Hudson SV, Chubak J, Coups EJ, Blake-Gumbs L, Jacobsen PB, Neugut AI, Buist DS. Identifying key questions to advance research and practice in cancer survivorship follow-up care: a report from the ASPO Survivorship Interest Group.  Cancer Epidemiol Biomarkers Prev. 2009;18(7):2152-4. PubMed

Tanvetyanon T, Qin D, Padhya T, McCaffrey J, Zhu W, Boulware D, DeConti R, Trotti A. Outcomes of postoperative concurrent chemoradiotherapy for locally advanced major salivary gland carcinoma. Arch Otolaryngol Head Neck Surg. 2009 Jul;135(7):687-92. PubMed